Back
Vanguard Short-Term Tax-Exempt Bond ETF Vs. Cidara Therapeutics Industry Stock Comparison
Sell
28
VTES
Vanguard Short-Term Tax-Exempt Bond ETF
Last Price:
$101.62
Seasonality Move:
-0.47%
Buy
77
CDTX
Cidara Therapeutics
Last Price:
$63.02
Seasonality Move:
2.01%
Sell
28
Vanguard Short-Term Tax-Exempt Bond ETF (VTES)
is a Sell
Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?
-
The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.59. The Score for VTES is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
VTES is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VTES Stock Price Chart
What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?
-
The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $62.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
VTES Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 27.38 | Buy |
Relative Strength Index (14 RSI): | 82.93 | Buy |
Chaikin Money Flow: | 20464 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (101.06 - 101.44) | Buy |
Bollinger Bands (100): | (99.92 - 101.08) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.72 | Buy |
Relative Strength Index (14 RSI): | 66.1 | Buy |
Chaikin Money Flow: | -71329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.74 - 63.84) | Buy |
Bollinger Bands (100): | (16.87 - 51.01) | Buy |
VTES Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.49 | Buy |
20-day SMA: | 101.3 | Buy |
50-day SMA: | 100.94 | Buy |
200-day SMA: | 100.56 | Buy |
8-day EMA: | 95.11 | Buy |
20-day EMA: | 67.72 | Buy |
50-day EMA: | 36.12 | Buy |
200-day EMA: | 10.57 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.11 | Sell |
20-day SMA: | 61.15 | Buy |
50-day SMA: | 46.89 | Buy |
200-day SMA: | 27.08 | Buy |
8-day EMA: | 58.14 | Buy |
20-day EMA: | 41.46 | Buy |
50-day EMA: | 22.13 | Buy |
200-day EMA: | 6.48 | Buy |
Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.
Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |